Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Fujiwara

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|February 19, 2024
The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-AnalysisSiddharth Agarwal, Usama Qamar, Yu Fujiwara, et al.
NPJ Precision Oncology|April 28, 2026
Orchestration of B and T cells predicts prolonged survival after cancer immune checkpoint inhibitor therapyYu Fujiwara, Shumei Kato, Daisuke Nishizaki, et al.
Cancer|September 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trialsAlexander B Karol, Rodrigo Paredes, Anna Argulian, et al.
Blood Neoplasia|August 14, 2025
Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphomaYoshito Nishimura, Yiqun Han, Nadia Toumeh, et al.
JCO Global Oncology|February 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022)Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 21, 2020
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxelNaoki Fukuda, Yu Fujiwara, Xiaofei Wang, et al.
Iscience|April 18, 2024
High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapyYu Fujiwara, Shumei Kato, Daisuke Nishizaki, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2025
CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonistsYuji Uehara, Daisuke Nishizaki, Yu Fujiwara, et al.
Journal of Geriatric Oncology|May 25, 2023
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatinYu Fujiwara, Yasuyoshi Sato, Naomi Hayashi, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|April 15, 2025
Adult-onset epilepsy with startle-induced seizure after febrile infection-related epilepsy syndrome: A case reportKazutoshi Konomatsu, Yosuke Kakisaka, Kazutaka Jin, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|February 19, 2024
The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-AnalysisSiddharth Agarwal, Usama Qamar, Yu Fujiwara, et al.
NPJ Precision Oncology|April 28, 2026
Orchestration of B and T cells predicts prolonged survival after cancer immune checkpoint inhibitor therapyYu Fujiwara, Shumei Kato, Daisuke Nishizaki, et al.
Cancer|September 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trialsAlexander B Karol, Rodrigo Paredes, Anna Argulian, et al.
Blood Neoplasia|August 14, 2025
Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphomaYoshito Nishimura, Yiqun Han, Nadia Toumeh, et al.
JCO Global Oncology|February 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022)Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 21, 2020
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxelNaoki Fukuda, Yu Fujiwara, Xiaofei Wang, et al.
Iscience|April 18, 2024
High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapyYu Fujiwara, Shumei Kato, Daisuke Nishizaki, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2025
CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonistsYuji Uehara, Daisuke Nishizaki, Yu Fujiwara, et al.
Journal of Geriatric Oncology|May 25, 2023
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatinYu Fujiwara, Yasuyoshi Sato, Naomi Hayashi, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|April 15, 2025
Adult-onset epilepsy with startle-induced seizure after febrile infection-related epilepsy syndrome: A case reportKazutoshi Konomatsu, Yosuke Kakisaka, Kazutaka Jin, et al.
Pageof 7